MHY1485
SIGMA/SML0810 - ≥95% (HPLC)
Synonym: 4,6-
CAS Number: 326914-06-1
Empirical Formula (Hill Notation): C17H21N7O4
Molecular Weight: 387.39
Linear Formula: C17H21N7O4
Product Type: Chemical
| assay | ≥95% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C17H21N7O4/c25-24(26)1 |
| InChI key | MSSXBKQZZINCRI-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [N+](=O)([O-])c1ccc(cc1)N |
| solubility | DMSO: 2 mg/mL, clear (warmed) |
| storage temp. | 2-8°C |
| Application: | MHY1485 has been used: • to study the effect of mammalian target of rapamycin mTOR signalling on in vitro O-GlcNAcylation • to inhibit autophagy • as a mTOR agonist to demonstrate that the O-linked N-acetylglucosamine transferase- RNA helicase p68 (OGT-DDX5) axis regulates colorectal cancer cell proliferation and metastasis |
| Biochem/physiol Actions: | MHY1485 binds to the mammalian target of rapamycin (mTOR) and stimulates its action. MHY1485 has the ability to penetrate the cell. It prevents the ultraviolet-induced oxidative stress in keratinocytes and fibroblasts. |
| Biochem/physiol Actions: | MHY1485 is mTOR activator that potently inhibits autophagy by suppression of fusion between autophagosomes and lysosomes. |
| Biochem/physiol Actions: | MHY1485 is mTOR activator: autophagy inhibitor. |
| Features and Benefits: | This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound is featured on the PKB/Akt page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥95% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

